Report overview
The global Factor IX Complex market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The U.S. market size is estimated at $ million in 2024, while China is to reach $ million.
500 IU Factor IX/Bottle (20ml) segment will reach $ million by 2032, with a % CAGR in next six years.
The global key manufacturers of Factor IX Complex include Grifols, CSL Behring, Alpha Therapeutic Corp, Octapharma AG, Baxter International Inc, Hualan Biological Engineering, Shanghai Raas Blood Products Co. Ltd, China Biologic Products Holdings, Inc, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
We have surveyed the Factor IX Complex manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Factor IX Complex, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Factor IX Complex. This report contains market size and forecasts of Factor IX Complex in global, including the following market information:
Global Factor IX Complex market revenue, 2020-2025, 2026-2032, ($ millions)
Global Factor IX Complex market sales, 2020-2025, 2026-2032, (K Bottles)
Global top five Factor IX Complex companies in 2024 (%)
Total Market by Segment:
Global Factor IX Complex market, by Type, 2020-2025, 2026-2032 ($ millions) & (K Bottles)
Global Factor IX Complex market segment percentages, by Type, 2024 (%)
500 IU Factor IX/Bottle (20ml)
1000 IU Factor IX/Bottle (40ml)
Global Factor IX Complex market, by Application, 2020-2025, 2026-2032 ($ Millions) & (K Bottles)
Global Factor IX Complex market segment percentages, by Application, 2024 (%)
Prevent Bleeding Episodes in People with Factor IX Deficiency
Treat Bleeding Episodes in People with Factor IX Deficiency
Other
Global Factor IX Complex market, by region and country, 2020-2025, 2026-2032 ($ millions) & (K Bottles)
Global Factor IX Complex market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Factor IX Complex revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Factor IX Complex revenues share in global market, 2024 (%)
Key companies Factor IX Complex sales in global market, 2020-2025 (estimated), (K Bottles)
Key companies Factor IX Complex sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Grifols
CSL Behring
Alpha Therapeutic Corp
Octapharma AG
Baxter International Inc
Hualan Biological Engineering
Shanghai Raas Blood Products Co. Ltd
China Biologic Products Holdings, Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Factor IX Complex, market overview.
Chapter 2: Global Factor IX Complex market size in revenue and volume.
Chapter 3: Detailed analysis of Factor IX Complex manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Factor IX Complex in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Factor IX Complex capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
